GeneDx Holdings Overview
GeneDx Holdings (WGS) has a P/E ratio of -21.45, below the Healthcare sector average of 25.93.
Get informed when a big investor buys or sells
+ Follow-21.45
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
GeneDx Holdings (WGS) currently reports a P/E ratio of -21.45. That is below the Healthcare sector average of 25.93. Use the charts on this page to explore GeneDx Holdings's P/E ratio history and peer comparisons.
GeneDx Holdings's P/E ratio of -21.45 is lower than the Healthcare sector average of 25.93. That is roughly 182.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates GeneDx Holdings's market price to a fundamental measure such as earnings, sales, or book value. At -21.45, WGS can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -21.45, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.93. From there, open related valuation or income-statement pages for GeneDx Holdings, and consider following WGS for alerts when major investors trade the stock.
GeneDx Holdings is classified in the Healthcare sector. On P/E ratio, it currently shows -21.45 versus a sector average near 25.93. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing WGS with unrelated industries.
